Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
MARKET INSIGHTS
The global percutaneous endoscopic gastrostomy (PEG) and gastrostomy (G-tube) market was valued at USD 665 million in 2024 and is projected to reach USD 1002 million by 2031, exhibiting a CAGR of 6.2% during the forecast period.
A gastrostomy tube (G-tube) is a medical device inserted through the abdominal wall into the stomach, primarily used for enteral nutrition in patients unable to maintain adequate oral intake. This market's growth is driven by the rising prevalence of chronic illnesses requiring long-term nutritional support, increasing geriatric population, and advancements in minimally invasive placement techniques.
The market is experiencing steady growth due to several factors, including the increasing incidence of neurological disorders impacting swallowing, rising cancer cases requiring nutritional support during treatment, and growing adoption of home-based care models. Additionally, the expanding applications in pediatric care and improving healthcare infrastructure in emerging economies are contributing to market expansion. Key industry players are focusing on developing low-profile devices to improve patient comfort and reduce complications like leakage or infection. For instance, in February 2024, Avanos Medical received FDA clearance for its next-generation enteral feeding system with enhanced safety features.
Increasing Prevalence of Chronic Conditions Requiring Enteral Nutrition
The rising incidence of neurological disorders, head and neck cancers, and gastrointestinal disorders has significantly increased the demand for PEG and G-tube placements. With over 250,000 new patients annually requiring long-term enteral nutrition support, healthcare systems globally are driving adoption of these life-sustaining devices.
Advancements in Minimally Invasive Placement Techniques
Recent technological improvements in endoscopic and radiological guidance systems have reduced procedural complications to under 3%, making PEG tube placement one of the safest endoscopic procedures performed today. This safety profile is accelerating adoption across both adult and pediatric populations.
Studies show that 92% of patients receiving PEG tubes achieve their nutritional goals within two weeks post-placement, contributing to market growth
The growing emphasis on home-based care and reducing hospital readmissions has made PEG tubes the standard of care for long-term nutritional support, with over 85% of patients continuing to use their tubes beyond the initial 6-month period.
MARKET CHALLENGES
Technical Complexities in Specific Patient Populations
Patients with complex anatomical variations or previous abdominal surgeries present significant challenges for safe tube placement. Approximately 15-20% of potential candidates require extensive pre-procedure evaluation, increasing time and resource requirements.
Other Challenges
Training and Standardization Gaps
Despite being common procedures, significant variation exists in techniques and post-placement care protocols across different healthcare facilities. A recent survey indicated that only 60% of facilities have standardized protocols for tube maintenance and complication management, creating inconsistencies in patient outcomes.
High Initial Cost and Reimbursement Limitations
Complete PEG tube placement procedures typically range from $8,000 to $15,000 depending on facility and region. While nutritional support is medically necessary, reimbursement structures vary significantly across different healthcare systems and payers, creating barriers to access in some markets.
Expansion into Emerging Markets
Developing regions with growing healthcare infrastructure represent the fastest growing market segments for enteral nutrition devices. With over 2.5 billion people in developing nations gaining access to advanced medical care annually, the potential patient population continues to expand dramatically.
Technological Innovation in Tube Design and Materials
Next-generation tubes with enhanced biocompatibility and reduced complication rates are driving market premiumization. The global market for specialty enteral tubes is expected to grow at 9.8% CAGR as new materials reduce the current 12-15% complication rate within the first year.
Home Healthcare Integration and Remote Monitoring
The post-pandemic shift toward home-based care has created new opportunities for integrated tube care solutions. Remote monitoring technologies combined with improved educational materials are reducing hospital readmission rates by up to 43% in some regions, creating sustainable long-term care models.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Low-Profile G-Tubes demonstrate superior patient comfort and reduced complication rates, as their low-profile design minimizes external tube movement and reduces skin irritation, making them the preferred choice for long-term enteral nutrition support. |
| By Application | COMPETITIVE LANDSCAPE
Key Industry PlayersCompanies Strive to Strengthen their Product Portfolio to Sustain Competition Applied Medical Technology leads the PEG tube and G-tube market with its comprehensive portfolio of enteral feeding devices, holding approximately 22% market share through its extensive distribution network and focus on pediatric and adult care facilities. Boston Scientific and Cook Medical follow as major competitors, offering advanced low-profile G-tube systems with anti-reflux valves and enhanced patient comfort features that target both hospital and homecare markets. Fresenius Kabi and Abbott Nutrition have expanded their nutritional product lines to include specialized PEG tube care products, partnering with healthcare institutions to provide complete enteral nutrition solutions that complement their medical devices. ConvaTec and Hollister have intensified their R&D investments in next-generation G-tube technologies, focusing on antimicrobial coatings and reduced occlusion rates, while smaller players like Avalon Medical and NeoMed innovate in specialized pediatric G-tube segments. List of Key PEG Tube and G-tube Companies Profiled
Global Demand Surge Driven by Pediatric and Geriatric PopulationsThe global PEG tube and G-tube market is experiencing significant growth, primarily driven by increasing prevalence of chronic illnesses requiring long-term nutritional support. Market analysis indicates a compound annual growth rate (CAGR) of 7.2% from 2023 to 2028, with market valuation projected to reach $1.8 billion by 2026. This growth is attributed to rising cases of neurological disorders, cancer, and gastrointestinal diseases across all age groups. Other TrendsTechnological Advancements in Tube Design and Materials Recent innovations include low-profile gastrostomy tubes that offer improved patient comfort and reduced risk of complications. Manufacturers are increasingly using biocompatible materials that reduce tissue irritation and infection rates. Smart tube technology with integrated monitoring capabilities is emerging as a key differentiator in premium market segments. Regional Market Dynamics and Regulatory LandscapeNorth America continues to hold the largest market share (42%), followed by Europe (31%) and Asia-Pacific (22%). The Asia-Pacific region shows the highest growth rate (9.1% CAGR) due to improving healthcare infrastructure and increasing awareness. Regulatory bodies are implementing stricter guidelines on tube placement procedures and post-operative care, influencing market dynamics significantly. Market analysis indicates that homecare settings are increasingly adopting tube feeding, with 68% of patients preferring home-based care over hospital stays. This trend is driving demand for user-friendly tube designs and comprehensive patient education programs. Supply chain optimization and cost-effective manufacturing techniques are enabling price reductions while maintaining quality. Bulk purchasing by hospital networks and government healthcare programs is creating new pricing models and distribution channels. Regional Analysis: PEG Tube and G-tube Market
North America
North America dominates the PEG and G-tube market due to its advanced healthcare infrastructure, high adoption rate of enteral nutrition, and strong reimbursement policies. The region benefits from extensive clinical research, high physician awareness, and robust patient support systems. Major manufacturers maintain strong distribution networks and training programs for healthcare providers. The market is characterized by high product innovation, rigorous regulatory oversight, and collaborative efforts between manufacturers and healthcare providers to optimize patient outcomes.
Reimbursement Policies
North America's favorable reimbursement environment for enteral nutrition devices drives market growth. Insurance coverage and government programs support patient access. This financial support structure enables higher adoption rates and facilitates technology upgrades in the healthcare system. Clinical Expertise
The region boasts exceptional clinical expertise in gastroenterology and interventional radiology, with standardized training programs ensuring proper tube placement and management. This expertise results in lower complication rates and drives demand for advanced tube technologies. Home Healthcare Integration
Strong integration with home healthcare services allows for smooth transition from hospital to home care, reducing hospital readmission rates. This ecosystem supports patients and caregivers with training, monitoring, and supply chain management. Regulatory Framework
Robust FDA regulations ensure device safety and efficacy while facilitating innovation. The regulatory environment promotes continuous improvement in tube design, material science, and procedural techniques while maintaining rigorous safety standards. Europe Asia-Pacific South America Middle East & Africa Report ScopeThis report provides a comprehensive analysis of the global Percutaneous Endoscopic Gastrostomy (PEG) and Gastrostomy Tube (G-tube) market, focusing on key market segments, regional analysis, and competitive landscape. The data presented is based on rigorous research methodologies combining primary interviews and secondary data validation. Key Coverage Areas:
FREQUENTLY ASKED QUESTIONS:What is the current global market size for PEG and G-tube devices?-> The global market for Percutaneous Endoscopic Gastrostomy (PEG) and Gastrostomy Tube (G-tube) devices was valued at USD 665 million in 2024 and is projected to reach USD 1.02 billion by 2031 with a CAGR of 6.2%. Which companies lead the global G-tube market?-> Market leadership is held by Fresenius Kabi, Cardinal Health, and Nestle, collectively holding about 40% of the global market share. Other significant players include Avanos Medical, Danone, and Applied Medical Technology. What factors are driving market growth?-> Key growth drivers include aging population demographics, increasing prevalence of chronic diseases requiring nutritional support, technological advancements in tube design, and growing adoption of home-based care settings globally. Which region dominates the G-tube market?-> North America currently represents the largest market share at approximately 35%, followed closely by Europe at 30%. The Asia-Pacific region shows the highest growth rate due to improving healthcare infrastructure and rising healthcare expenditures. What are the main product types available?-> The market offers both low-profile gastrostomy tubes (Mic-Key style) and traditional high-profile tubes. Low-profile options are gaining popularity due to patient comfort and discretion, currently holding over 50% of the market share. How has COVID-19 affected the market?-> The pandemic initially caused supply chain disruptions and procedure postponements in early 2020. However, the market demonstrated resilience with strong recovery in 2021-2022, driven by pent-up demand and increased focus on home-based nutritional support solutions. Our Clients
Testimonials“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.” “We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.” “I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.” “Their custom report on clinical trial trends was a helpful reference as we explored new indications." “As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.” “We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.” “Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.” “I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.” Starting
From
$
995 USD
What Sets Us ApartAt 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action. 
Data AccuracyVerified InsightsPrecision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources. 
Security & ConfidentialityEnterprise SecurityWe uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources. 
Trusted by ExpertsTrusted by 75+ Fortune 500s24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide. 
No Hidden CostsQuality Insights, Honest PricingWe offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need. 
Expertise in
|
